Fort Lee, New Jersey, USA, March 2, 2015 (GLOBE NEWSWIRE) -- Herborium® Group, Inc.(OTC Pink: HBRM), www.Herborium.com, a Botanical Therapeutics® Company providing unique, all botanical medicines (Botanical Therapeutics®), announced today its 2014 financial results. The company filed a full Financial Report with Legal Opinion on OTC, on Friday February 28th, 2015.
The Company results for 2014 have significantly surpassed expectations and indicate a rapid growth, and a strong improvement over 2013.
§ Herborium sales in 2014 grew 79% in comparison to 2013 (from $381,000.00 to $684,000.00). Herborium surpassed the total annual sales for 2013 in the Third Quarter of 2014.
§ The Company's gross profit increased by $190,000.00 from $236,000.00 in 2013 to $429,000.00 in 2014 what represents 80% growth over 2013.
§ The highly significant increase in Herborium's revenues and gross profit has been combined with INCREASE IN COMPANY'S MARGIN that grew from 61.9% in 2013 to 62.9% in 2014.
§ 2014 annual loss from operations was decreased by 43% comparing to 2013.
§ Herborium's lead product, AcnEase®, achieved a milestone of over 10,000 "likes" on the Facebook in the USA, what represents increase of 35% over 2013. Newly established French Facebook reached over 1000 "likes" in the first 4 weeks after its opening.
The overall growth in revenues, gross profit and gross margin achieved by the Company in 2014, combined with decrease in loss from operations and further improvement in brand recognition represent pivotal factors in Herborium's prospects for continuous and successful growth in 2015.
Herborium's Management plans to use those achievements as a springboard for expending company's presence in the US and global markets through an acquisition and development of additional distribution channels and new products. We expect the growth and profitability of our novel, all natural medicines - Botanical Therapeutics®" to continue in 2015 ", commented Dr. Agnes P. Olszewski, CEO and Chairwoman of Herborium Group.
About Herborium Group, Inc.
Herborium Group, Inc., a botanical therapeutics® company that develops, license and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. Herborium has secured a pipeline of botanical ingredients based products in the areas of dermatological needs, wellness and energy, prostate health, women's health and selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, diabetes, surgical procedures, and other problems. Herborium Group sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. For more information, please visit www.herborium.com, and www.acnease.com.
Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of Herborium Group, Inc., which involves risks and uncertainties. The Company's actual future results could materially differ from those discussed. The Company intends that such statements about the Company's future expectations, including future revenues and earnings, and all other forward looking statements be subject to the "Safe Harbors" provision of the Private Securities Litigation Reform Act of 1995.